News & Updates
Filter by Specialty:
Keto diet: Is there good evidence in MS?
A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.
Keto diet: Is there good evidence in MS?
23 May 2022
COVID-19 vaccine booster efficacy: What do new HK data show?
A booster dose of the mRNA-based BNT162b2 vaccine provides more robust antibody responses to SARS-CoV-2, including the Omicron BA.1 and BA.2 variants, than the inactivated CZ02 vaccine, but three doses of either vaccine are equally effective in reducing the risk of severe or fatal COVID-19, according to new local data presented at the 26th Hong Kong Medical Forum (HKMF).
COVID-19 vaccine booster efficacy: What do new HK data show?
23 May 2022
Which canagliflozin dose is best for T2DM patients with hypertension?
A recent meta-analysis offers new proof of different canagliflozin doses for hypertension management in patients with type 2 diabetes mellitus (T2DM) complicated by hypertension. However, low-density lipoprotein cholesterol (LDL-C) and the risk of urinary tract infection must be observed.
Which canagliflozin dose is best for T2DM patients with hypertension?
22 May 2022
Subjective cognitive decline a red flag for Alzheimer’s disease
Subjective cognitive decline appears to be indicative of stage 2 Alzheimer’s disease, where individuals exhibit mild changes in mood or behaviour and subtle objective cognitive decline although not to the point of meeting mild cognitive impairment criteria, as suggested in a study.
